•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
3M (MMM) has an established industrial legacy, but the stock’s recent performance has reflected a difficult period for the company. While the shares have generally risen over the past three years, investors should not assume volatility has ended, particularly as legal and business-transition issues continue to shape sentiment.
Supporters of 3M point to its broadly diversified industrial portfolio and a long track record of returning capital. Although the dividend was reduced in 2024 following the Solventum spin-off, the dividend has since been increased twice, indicating a return to growth.
On the operating side, the business has shown improvement. Adjusted earnings were up 10% in 2025, and adjusted earnings rose nearly 14% in the first quarter of 2026. The stock also offers an above-market dividend yield of 2.1%.
The largest structural change in recent years was the spin-off of Solventum (SOLV), which came from 3M’s former healthcare division—described as its fastest-growing business. Management pursued the separation to raise cash needed to address material legal issues tied to earplugs sold to the military and to “forever chemicals” the company has produced.
The spin-off is presented as the right move because it provides 3M more flexibility to address its legal challenges. However, the legal headwinds are not resolved, and the company is described as being unable to provide much information about the proceedings. That limits investors’ ability to track developments, increasing uncertainty.
One example cited from 2025 adjustments is the removal of $1.95 per share of litigation-related expenses from adjusted earnings.
For investors who have held the stock, the experience has been mixed. 3M is up nearly 70% over the past three years, but down 11% over the past five years. The shares are also about 15% below their 52-week high.
The article frames the current setup as one where volatility is likely to persist. Even if the long-term outlook improves as legal issues are resolved and growth continues after the Solventum separation, near-term market reactions are expected to remain sensitive to legal news, company financial results, and the inherent volatility of the cyclical industrial sector.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
